NewsRoom Articles - Page 854 of 1390

TuesdayMar 19, 2019 1:00 pm

Q BioMed Inc. (QBIO) Attends 31st Annual ROTH Conference

Q BioMed (OTCQB: QBIO) aims to accelerate the monetization of biomedical technologies through rapid innovation and collaborative partnerships with industry leading researchers. Q BioMed believes its assets in oncology, vascular disease, and rare orphan diseases address unmet medical needs and large markets. The company’s FDA approved, non-opioid drug Metastron, which relieves cancer bone pain, is expected to begin generating revenues in 2019. Metastron is also approved for sale in 21 other countries. In addition to treating pain, Metastron has shown evidence of treating the cancer itself and extending survival. Q BioMed plans to conduct Phase IV trials to support label…

TuesdayMar 19, 2019 1:00 pm

Purple Innovation Inc. (NASDAQ: PRPL) Attends 31st Annual ROTH Conference

Purple Innovation (NASDAQ: PRPL) is an innovative comfort product company that designs and manufactures products to improve people's lives. It designs and manufactures a range of comfort products, including mattresses, pillows, and cushions, using its patented Hyper-Elastic Polymer material designed to improve comfort. The company markets and sells its products through its direct-to-consumer online channel, traditional retail partners, and third-party online retailers. For more information, visit the company's website at www.purple.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries…

TuesdayMar 19, 2019 1:00 pm

Pulmatrix Inc. (NASDAQ: PULM) Attends 31st Annual ROTH Conference

Pulmatrix (NASDAQ: PULM) is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented iSPERSE™ technology. The company's proprietary product pipeline is focused on advancing treatments for serious lung diseases, including Pulmazole, inhaled anti-fungal itraconazole for patients with ABPA, and PUR1800, a narrow spectrum kinase inhibitor for patients with obstructive lung diseases including asthma and chronic obstructive pulmonary disease ("COPD"). In addition, Pulmatrix has partnered with Vectura Group plc to develop Pulmatrix's long-acting muscarinic antagonist drug candidate, PUR0200, for COPD for the U.S. market. For more information, visit the company's website at www.pulmatrix.com. About…

TuesdayMar 19, 2019 1:00 pm

Propanc Biopharma Inc. (PPCB) Attends 31st Annual ROTH Conference

Propanc Biopharma (OTCQB: PPCB) is a biopharmaceutical company developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The company has developed a formulation of anti-cancer compounds, which exert several effects designed to control or prevent tumors from recurring and spreading. The company's products involve or employ pancreatic proenzymes, which are inactive precursors of enzymes. The company initially intends to target patients with limited remaining therapeutic options for the treatment of solid tumors. In the future, the company intends to develop its lead product candidate, PRP, to treat early stage cancer and pre-cancerous diseases. For more information,…

TuesdayMar 19, 2019 1:00 pm

Profire Energy Inc. (NASDAQ: PFIE) Attends 31st Annual ROTH Conference

Profire Energy (NASDAQ: PFIE) assists energy production companies in the safe and efficient production and transportation of oil and natural gas. As energy companies seek greater safety for their employees, compliance with more stringent regulatory standards, and enhanced margins with their energy production processes, Profire Energy's burner management and chemical injection systems are increasingly becoming part of their solution. Profire Energy has offices in Lindon, Utah; Victoria, Texas; Homer, Pennsylvania; Greeley, Colorado; and Edmonton, Alberta, Canada. For more information, visit the company's website at www.ProfireEnergy.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1)…

TuesdayMar 19, 2019 1:00 pm

Crown Crafts Inc. (NASDAQ: CRWS) Attends 31st Annual ROTH Conference

Crown Crafts (NASDAQ: CRWS) designs, markets and distributes infant, toddler and juvenile consumer products and is one of America’s largest producers of infant bedding, toddler bedding, bibs and developmental toys. The company operates through its three wholly owned subsidiaries: NoJo Baby & Kids Inc., Sassy Baby Inc. and Carousel Designs LLC. The company’s subsidiaries market a variety of infant, toddler and juvenile products under company-owned trademarks, as well as licensed collections and exclusive private label programs. Sales are made directly to retailers such as mass merchants, large chain stores and juvenile specialty stores, as well as directly to consumers online.…

TuesdayMar 19, 2019 1:00 pm

Crocs Inc. (NASDAQ: CROX) Attends 31st Annual ROTH Conference

Crocs (NASDAQ: CROX) is a world leader in innovative casual footwear for women, men and children, combining comfort and style with a value that consumers know and love. Every pair of shoes within Crocs’ collection contains Croslite material, a proprietary, molded footwear technology, delivering extraordinary comfort with each step. Crocs believes that expressing yourself and being comfortable are not mutually exclusive. For more information, visit the company's website at www.crocs.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and…

TuesdayMar 19, 2019 1:00 pm

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) Attends 31st Annual ROTH Conference

Cresco Labs (CSE: CL) (OTCQX: CRLBF) is a U.S. cannabis company with experienced management, access to capital, and a demonstrated growth strategy. As a differentiated grower, processor and retailer of premium cannabis operating in seven states, the company focuses on entering highly regulated markets with outsized demand potential and high barriers to entry. Its impressive speed-to-market gives Cresco a distinct competitive advantage as it replicates its model to expand its national footprint. Cresco’s products are tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef inspired edibles. For more information, visit the company's website at www.crescolabs.com.…

TuesdayMar 19, 2019 1:00 pm

Rambus Inc. (NASDAQ: RMBS) Attends 31st Annual ROTH Conference

Rambus (NASDAQ: RMBS) creates innovative hardware, software and services that drive technology advancements from the data center to the mobile edge. The company architecture licenses, IP cores, chips, software, and services span memory and interfaces, security and emerging technologies to positively impact the modern world. Rambus collaborates with the industry, partnering with leading chip and system designers, foundries, and service providers. Integrated into tens of billions of devices and systems, our products and technologies power and secure diverse applications, including Big Data, Internet of Things (IoT) security, mobile payments, and smart ticketing. For more information, visit the company's website at…

TuesdayMar 19, 2019 1:00 pm

RA Medical Systems Inc. (NYSE: RMED) Attends 31st Annual ROTH Conference

RA Medical Systems (NYSE: RMED) commercializes excimer lasers and catheters for the treatment of dermatological and vascular diseases. In May 2017, DABRA laser system and disposable DABRA catheter received FDA 510(k) clearance in the U.S. for the intended use of ablating a channel in occlusive peripheral vascular disease. Pharos excimer laser system is FDA-cleared and is used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. DABRA and Pharos are both based on RaMedical’s core excimer laser technology platform and deploy similar mechanisms of action. For more information, visit the company's website at www.ramed.com. About NetworkNewsWire…